TLDR Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.
The study found that the chemotherapy drug doxorubicin disrupted the blood vessel network associated with hair follicles in ND-GFP transgenic mice, leading to reduced vessel density and dystrophic hair follicles, which contributed to chemotherapy-induced alopecia. However, it did not affect hair-follicle stem cells, allowing for potential hair regrowth after chemotherapy. The research highlighted the role of inhibited angiogenesis in hair follicle dystrophy and alopecia, providing a model for studying the effects of chemotherapy on hair follicles and tumors.
106 citations,
June 2005 in “Journal of Investigative Dermatology” The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.
76 citations,
March 2005 in “Cancer Research” Doxorubicin can block blood vessels from hair follicles, reducing skin tumor growth.
212 citations,
August 2004 in “Proceedings of the National Academy of Sciences” Hair follicle cells can create new blood vessels in the skin.
21 citations,
May 2022 in “Frontiers in Cell and Developmental Biology” Hair growth and health are influenced by factors like age, environment, and nutrition, and are controlled by various molecular pathways. Red light can promote hair growth, and understanding these processes can help treat hair-related diseases.
21 citations,
May 2016 in “Experimental and Therapeutic Medicine” MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.
April 2016 in “Journal of Investigative Dermatology” Wnt ligands, produced by dermal papilla cells, are essential for adult hair growth and regeneration.
